Skip to main content
. 2023 May 8;42(3):413–423. doi: 10.1038/s41587-023-01784-x

Fig. 1. Cellular immune responses against allogeneic rhesus macaque wt and HIP grafts.

Fig. 1

ae, Immune assays in the group receiving wtallo first. ELISpot assays with recipient monkey PBMCs drawn at scheduled timepoints (a, mean ± s.d., four monkeys). Killing assays with recipient monkey PBMCs (b), T cells (c), NK cells (d) and macrophages (e). Percent target cell killing is shown on the left y axis (mean ± s.d.), and killing speed is shown on the right y axis (killing t1/2−1, mean ± s.e.m., four monkeys). fj, Immune assays in the group receiving HIPallo first. ELISpot assays with recipient monkey PBMCs (f, mean ± s.d., four monkeys at weeks 0–7, three monkeys at week 8 and two monkeys at weeks 10–16). Killing assays with recipient monkey PBMCs (g), T cells (h), NK cells (i) and macrophages (j). Percent target cell killing is shown on the left y axis (mean ± s.d.), and killing speed is shown on the right y axis (killing t1/2−1, mean ± s.e.m., four monkeys at weeks 0–7, three monkeys at week 8 and two monkeys at weeks 10–16). All assays run against wtallo and HIPallo are shown in blue and red, respectively, at 6 weeks, and, later, all assays were run against both cell types.